文献速递哮喘

巨噬细胞功能障碍在哮喘发病与治疗中的作用

Macrophage dysfunction in the pathogenesis and treatment of asthma.
PubMed 文献 · Eur Respir J · 2017-09-12

本文综述哮喘中巨噬细胞功能障碍的临床证据,涉及不同炎症表型与治疗反应的关系,并探讨巨噬细胞作为治疗靶点的依据。作者认为巨噬细胞功能障碍在哮喘中普遍且异质,可能促进不同炎症表型,支持其作为疾病修饰因子、生物标志物和治疗靶点的研究方向。

要点

  • 哮喘中巨噬细胞功能障碍普遍且高度异质。
  • 巨噬细胞可能促进哮喘不同炎症表型。
  • 支持巨噬细胞作为生物标志物和治疗靶点研究。

核心结论

  • 哮喘中巨噬细胞功能障碍普遍且异质,可能促进不同炎症表型。
  • 支持继续研究巨噬细胞作为疾病修饰因子、生物标志物和治疗靶点。

研究设计与样本

  • 综述总结哮喘中巨噬细胞功能障碍的临床证据及治疗靶点证据。

主要发现

  • 哮喘气道存在多种炎症表型,与临床表型及对常规和新型治疗的反应相关。
  • 巨噬细胞是肺内丰富免疫细胞,能产生维持稳态和防御病原体所需多种反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma is a chronic respiratory condition frequently associated with aberrant airway and systemic inflammation. Various inflammatory phenotypes in asthmatic airways have been described that relate to clinical phenotypes and impact on responses to conventional and novel asthma therapies. Macrophages are abundant immunocytes in the lung, capable of mounting diverse responses required for homeostasis and defence against pathogens.Here, we summarise the clinical evidence regarding macrophage dysfunction in asthma. We also describe evidence supporting the role of macrophages as therapeutic targets in asthma. We conclude that macrophage dysfunction in asthma is highly prevalent and heterogeneous, and hypothesise that macrophages may play roles in promoting the discrete inflammatory phenotypes of asthma.These clinical findings, along with recent ground-breaking insights into the ontogeny, behavioural complexity and longevity of pulmonary macrophages, support continued research into the role of macrophages as disease modifiers, biomarkers and therapeutic targets in asthma.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Fricker M, Gibson PG. Macrophage dysfunction in the pathogenesis and treatment of asthma. Eur Respir J. 2017. PMID: 28899935. doi:10.1183/13993003.00196-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。